461 related articles for article (PubMed ID: 10933940)
21. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
[TBL] [Abstract][Full Text] [Related]
22. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
Klebba C; Ottmann OG; Scherr M; Pape M; Engels JW; Grez M; Hoelzer D; Klein SA
Gene Ther; 2000 Mar; 7(5):408-16. PubMed ID: 10694823
[TBL] [Abstract][Full Text] [Related]
23. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
Shields LE; Kiem HP; Andrews RG
Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
Leavitt MC; Yu M; Wong-Staal F; Looney DJ
Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of thymopoiesis of CD34+ cell maturation by HIV-1 in an in vitro CD34+ cell and thymic epithelial organ culture model.
Knutsen AP; Roodman ST; Freeman JJ; Mueller KR; Bouhasin JD
Stem Cells; 1999; 17(6):327-38. PubMed ID: 10606161
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV.
Ruiz ME; Cicala C; Arthos J; Kinter A; Catanzaro AT; Adelsberger J; Holmes KL; Cohen OJ; Fauci AS
J Immunol; 1998 Oct; 161(8):4169-76. PubMed ID: 9780190
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.
Berkowitz RD; Beckerman KP; Schall TJ; McCune JM
J Immunol; 1998 Oct; 161(7):3702-10. PubMed ID: 9759895
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC).
Sun L; Zhang Y; Huang CX; Qu XL; Zhang Y; Zhang JC; Wei X; Zhuang Y; Zhai S; Peng MJ; Jiang H; Hao CQ; Li YH; Lu J; Lian JQ; Sun YT; Bai XF
J Virol Methods; 2008 Dec; 154(1-2):194-9. PubMed ID: 18706447
[TBL] [Abstract][Full Text] [Related]
30. Intracellular immunization of rhesus CD34+ hematopoietic progenitor cells with a hairpin ribozyme protects T cells and macrophages from simian immunodeficiency virus infection.
Rosenzweig M; Marks DF; Hempel D; Heusch M; Kraus G; Wong-Staal F; Johnson RP
Blood; 1997 Dec; 90(12):4822-31. PubMed ID: 9389699
[TBL] [Abstract][Full Text] [Related]
31. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
Cagnon L; Rossi JJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
[TBL] [Abstract][Full Text] [Related]
33. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.
Anderson J; Li MJ; Palmer B; Remling L; Li S; Yam P; Yee JK; Rossi J; Zaia J; Akkina R
Mol Ther; 2007 Jun; 15(6):1182-8. PubMed ID: 17406343
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.
Yam P; Jensen M; Akkina R; Anderson J; Villacres MC; Wu J; Zaia JA; Yee JK
Mol Ther; 2006 Aug; 14(2):236-44. PubMed ID: 16647299
[TBL] [Abstract][Full Text] [Related]
37. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
[TBL] [Abstract][Full Text] [Related]
38. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.
Banerjea A; Li MJ; Bauer G; Remling L; Lee NS; Rossi J; Akkina R
Mol Ther; 2003 Jul; 8(1):62-71. PubMed ID: 12842429
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
